Abstract
The extent to which human telomerase reverse transcriptase (hTERT) mRNA and its splice variants control telomerase activity in human cancers is controversial. Telomerase and hTERT mRNA were assessed quantitatively in paired samples of gastric adenocarcinoma and adjacent normal tissue. Splice variants within the hTERT reverse transcriptase domain (α, β, α β) were detected by RT-PCR. In gastric adenocarcinoma, compared to normal tissue, median telomerase activity increased significantly (from 0 total product generated [tpg; 95% confidence interval CI, 0–2.3] to 16.1 tpg [95% CI, 3.7–97]; P = 0.008) and median hTERT mRNA levels also increased (from 2.21 [95% CI, 1.40–4.62] to 7.08 [95% CI, 3.26–10.8]; P = 0.0054). hTERT mRNA and telomerase activity correlated in normal gastric mucosa (r = 0.819, P = 0.0002). α, β, and αβ deletions were similar in both groups. We conclude that hTERT mRNA partially regulates telomerase activity in normal gastric mucosa and gastric adenocarcinoma. In contrast, hTERT mRNA splicing is not involved in the regulation of enzyme activity.
Similar content being viewed by others
References
World Health Organization: The World Health Report 2000: Health Systems, Improving Performance. Geneva, WHO, 2000
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1132, 1991
Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33(5):787–791, 1997
Usselmann B, Newbold M, Morris AG, Nwokolo CU: Telomerase activity and patient survival after surgery for gastric and esophageal cancer. Eur J Gastroenterol Hepatol 13(8):903–908, 2001
Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 279:349–352, 1998
Nakayama JI, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T, Ishikawa F: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18:65–68, 1998
Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA: hEST2, putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785–795, 1997
Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR: Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58:4168–4172, 1998
Brenner CA, Wolny YM, Adler RR, Cohen J: Alternative splicing of the telomerase catalytic subunit in human oocytes and embryos. Mol Hum Reprod 5(9):845–850, 1999
Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, Reddel, RR: The hTERTα splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2:426–432, 2000
Yi X, White DM, Aisner DL, Baur JA, Wright WE, Shay JW: An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2(5):433–440, 2000
Wang J, Xie LY, Allan S, Beach D, Hannon GJ: Myc activates telomerase. Genes Dev 12:1769–1774, 1998
Kyo S, Takakura M, Kanaya T, Wang Z, Fujimoto K, Nishio Y, Orimo A, Inoue M: Estrogen activates telomerase. Cancer Res 59:5917–5921, 1999
Wang Z, Kyo S, Takakura M, Tanaka M, Yatabe N, Maida Y, Fujiwara M, Hayakawa J, Ohmichi M, Koike K, Inoue M: Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway. Cancer Res 60:5376–5381, 2000
Oh S, Song Y, Yim J, Kim T: The Wilms’ tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. J Biol Chem 274:37473–37478, 1999
Oh S, Song YH, Yim J, Kim TK: Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene 19:1485–1490, 2000
Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, Inoue M: Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res 6:1239–1247, 2000
Kim NW, Wu F: Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 25(13):2595–2597, 1997
Sachs L: Applied Statistics: A Handbook of Techniques. New York, Springer Verlag, 1982, pp 317–318
Nakamura Y, Tahara E, Tahara H, Yasui W, Tahara E, Ide T: Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues. Mol Carcinog 26:312–320, 1999
Yasui W, Tahara H, Tahara E, Fujimoto J, Nakayama JI, Ishikawa F, Ide T, Tahara, E: Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas. Jpn J Cancer Res 89:1099–1103, 1998
Jong HS, Park YI, Kim S, Sohn JH, Kang SH, Song SH, Bang YJ, Kim NK: Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer 86:559–565, 1999
Suzuki K, Kashimura H, Ohkawa J, Itabashi M, Watanabe T, Sawahata T, Nakahara A, Muto H, Tanaka N: Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions. J Gastroenterol Hepatol 15:744–751, 2000
Li H, Zhao L, Yang Z, Funder JW, Liu JP: Telomerase is controlled by protein kinase Cα in human breast cancer cells. J Biol Chem 273(50):33436–33442, 1998
Kharbanda S, Kumar V, Dhar S, Pandey P, Chen C, Majumder P, Yuan ZM, Whang Y, Strauss W, Pandita TK, Weaver D, Kufe D: Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase. Curr Biol 10:568–575, 2000
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barclay, J.Y., Morris, A.G. & Nwokolo, C.U. hTERT mRNA Partially Regulates Telomerase Activity in Gastric Adenocarcinoma and Adjacent Normal Gastric Mucosa. Dig Dis Sci 50, 1299–1303 (2005). https://doi.org/10.1007/s10620-005-2776-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-2776-5